Positive recommendation based on phase II NOBILITY and phase III REGENCY data showing Gazyva/Gazyvaro’s superiority over standard therapy alone1,2Gazyva/Gazyvaro is the only anti-CD20 antibody to ...

Positive recommendation based on phase II NOBILITY and phase III REGENCY data showing Gazyva/Gazyvaro's superiority over standard therapy alone1,2 Gazyva/Gazyvaro is the only anti-CD20 antibody to ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

In APPLAUSE-IgAN final analysis, Fabhalta demonstrated statistically significant, clinically meaningful improvement in estimated glomerular filtration rate (eGFR) slope vs. placebo over two years1eGFR ...

GFR is key marker of kidney function; IgAN is progressive autoimmune kidney disease that leads to kidney failure in many patients1-3 Fabhalta is first and only approved complement inhibitor for adults ...

PRESS RELEASE DETERA Therapeutics Wins the Ipsen Golden Ticket 2025 A strategic recognition of the biotech’s potential by a ...

Learn about the racial bias in organ transplant algorithms that disadvantaged Black patients. Discover how the system is ...

When the human body gets hurt, most tissues heal—skin closes over a wound, bone heals itself. But not all organs heal that ...

Medical second opinions have evolved from a patient-requested reassurance to a core component of value-based healthcare. With ...

These small-yet-powerful organs play a vital role in your body, so why not consume superfoods that can better support your health?

A new pill called baxdrostat may offer hope for people whose blood pressure stays high even after taking standard medications ...

The global Renal Cyst Treatment Market is on a trajectory of steady expansion, with its estimated value at USD 203.2 million ...